Piccolo Trglycerides-Capillary Test System
Colorimetric Method, Triglycerides. 510(k) K120664, from Abaxis, Inc. (Union City, CA). Product code JGY, class 1.
As of Nov 18, 2026, K120664 is an FDA 510(k) held by Abaxis, Inc., substantially equivalent on Apr 24, 2012 after 50 days, with no recalls tied to it in FDA's recall database.
- Review time: 50 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFTriglyceride measurements are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, and other diseases involving lipid metabolism, or various endocrine disorders.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Piccolo Triglycerides Test SystemK023639 · Abaxis, Inc. · Jan 24, 2003
- Roche Reagent for TriglyceridesK893973 · Roche Diagnostic Systems, Inc. · Aug 11, 1989
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 5, 2012
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1705
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files